Stock Opinions by Bill Baruch, Founder, Blue Line Capital

Most recent Opinions go here

Be up to date, don't miss your chance.

BUY
Down on weak outlook

Bought it at $220. Revenue growth from data centres is accelerating, with full year 2027 growth at 60%. From their report, he wanted to see a bigger beat and EPS, perhaps from over-expectations. CXL and connectivity will continue to expand. 

BUY

Is bullish minerals which are a great alternative to bonds. Buy on pullbacks. NEM approached previous highs recently. Also, likes AEM.

BUY

Terrific earnings report this week. It's his largest holding.

COMMENT
Reporting toay

He'll watch what they say about memory costs and the impact on margins, and comments on their financing deal as well as comments on non-GPU products. These comments could shake things up positively.

BUY

He added shares 2 weeks ago. They enjoy a big backlog while no new debt is expected in 2026. If AI succeeds, so will Oracle. Their EPS is growing over 20%. It's a great time to buy.

HOLD

He's holding onto his large position as he battles this volatility. Their CTO left, which pressured shares. Customer retention remains strong, though. The stock will find its way higher after this earnings report.

BUY

He still thinks yields will decline which may be a tailwind. VST has partnerships with Nvidia and KKR, and data centres continue to need power. They have great nuclear and gas contracts. The CEO bought some shares recently.

BUY

Micron has momentum. Nvidia's report a blow-out today and will lift Micron higher. 

STRONG BUY

He's excited by the neocloud story. Trades at 18x forward PE. The software headwinds have weakened. If AI succeeds, Oracle succeeds.

BUY

He added more Nvidia because he was underweight it, trades at 20x PE forward at 100% earnings growth, and the 200-day moving average looks great. It typically runs up before earnings.

BUY

It's a 2027 story on compute which will enjoy great tailwinds for the rest of the year.

RISKY

An AI infrastructure story and a growth story. It sold off 40% from its recent high. Volatile, but thinks it will snap back quickly.

BUY

It reports Monday. They benefit from reshoring and energy. Will do well.

BUY

Has 7% earnings growth. New drugs have made up the lost revenue of Humera. It projects 24% revenue growth. He likes healthcare. Sees it breaking out.

BUY

He bought. Gold has good seasonality in July, and the chart looks constructive now. He doesn't think the Fed will raise rates this year, because Trump will keep rates low heading into the US Midterms in November. And gold is the way to play it.

Showing 1 to 15 of 119 entries